Claudio Fortis

1.1k total citations
42 papers, 915 citations indexed

About

Claudio Fortis is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Claudio Fortis has authored 42 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 10 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Claudio Fortis's work include Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (10 papers) and HIV Research and Treatment (8 papers). Claudio Fortis is often cited by papers focused on Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (10 papers) and HIV Research and Treatment (8 papers). Claudio Fortis collaborates with scholars based in Italy, United Kingdom and Nigeria. Claudio Fortis's co-authors include Luca Gianotti, Laura Galli, Adriano Lazzarin, Laura Soldini, Giovanni Citterio, Valerio Di Carlo, Giuseppe Consogno, Oreste ­Gentilini, Giuseppe Tambussi and Alessandro Poggi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancer Research.

In The Last Decade

Claudio Fortis

42 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Fortis Italy 16 529 200 144 140 121 42 915
William Kopp United States 15 351 0.7× 280 1.4× 76 0.5× 203 1.4× 77 0.6× 26 978
Jean-François Bach France 14 360 0.7× 129 0.6× 82 0.6× 227 1.6× 71 0.6× 19 1.1k
V. Tricottet France 14 279 0.5× 117 0.6× 156 1.1× 170 1.2× 98 0.8× 19 820
A D Levine United States 11 410 0.8× 95 0.5× 82 0.6× 180 1.3× 84 0.7× 19 856
M W Hilgartner United States 14 300 0.6× 77 0.4× 61 0.4× 59 0.4× 137 1.1× 19 1.1k
J. Economidou Greece 18 250 0.5× 114 0.6× 99 0.7× 178 1.3× 21 0.2× 53 1.2k
Sanit Makonkawkeyoon Thailand 9 129 0.2× 99 0.5× 152 1.1× 250 1.8× 88 0.7× 20 862
Andreas Weimann Germany 16 123 0.2× 58 0.3× 91 0.6× 155 1.1× 156 1.3× 47 773
Maria E. Moreno‐Fernandez United States 20 545 1.0× 81 0.4× 72 0.5× 447 3.2× 236 2.0× 38 1.1k
C. Vincent France 18 272 0.5× 121 0.6× 95 0.7× 113 0.8× 12 0.1× 63 1.1k

Countries citing papers authored by Claudio Fortis

Since Specialization
Citations

This map shows the geographic impact of Claudio Fortis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Fortis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Fortis more than expected).

Fields of papers citing papers by Claudio Fortis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Fortis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Fortis. The network helps show where Claudio Fortis may publish in the future.

Co-authorship network of co-authors of Claudio Fortis

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Fortis. A scholar is included among the top collaborators of Claudio Fortis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Fortis. Claudio Fortis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiara, Giulia Della, Claudio Fortis, Giuseppe Tambussi, & Guido Poli. (2010). The rise and fall of intermittent interleukin-2 therapy in HIV infection.. PubMed. 21(3). 197–201. 5 indexed citations
2.
Titanji, Kehmia, Stefano Sammicheli, Angelo De Milito, et al.. (2007). Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus‐1 infection. Immunology. 123(2). 164–170. 22 indexed citations
3.
Piana, Federica, Luigi Ruffo Codecasa, Laura Galli, et al.. (2006). Comparison of an In-house and a Commercial RD1-based ELISPOT-IFN-  Assay for the Diagnosis of Mycobacterium tuberculosis Infection. Clinical Medicine & Research. 4(4). 266–272. 15 indexed citations
4.
Scarpellini, Paolo, et al.. (2004). Selected Pool of Peptides from ESAT-6 and CFP-10 Proteins for Detection of Mycobacterium tuberculosis Infection. Journal of Clinical Microbiology. 42(8). 3469–3474. 37 indexed citations
5.
Biswas, Priscilla, Marina Ferrarini, Barbara Mantelli, et al.. (2003). Double‐edged effect of Vγ9/Vδ2 T lymphocytes on viral expression in an in vitro model of HIV‐1/mycobacteria co‐infection. European Journal of Immunology. 33(1). 252–263. 15 indexed citations
6.
Tambussi, Giuseppe, Silvia Nozza, Brunella Capiluppi, et al.. (2003). Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis. AIDS. 17(16). 2291–2298. 48 indexed citations
7.
Fortis, Claudio, Laura Soldini, Silvia Ghezzi, et al.. (2002). Tumor Necrosis Factor α , Interleukin 2, and Soluble Interleukin 2 Receptor Levels in Human Immunodeficiency Virus Type 1-Infected Individuals Receiving Intermittent Cycles of Interleukin 2. AIDS Research and Human Retroviruses. 18(7). 491–499. 7 indexed citations
8.
Poggi, Alessandro, Roberta Carosio, Grazia Maria Spaggiari, et al.. (2002). NK Cell Activation by Dendritic Cells Is Dependent on LFA-1-Mediated Induction of Calcium-Calmodulin Kinase II: Inhibition by HIV-1 Tat C-Terminal Domain. The Journal of Immunology. 168(1). 95–101. 64 indexed citations
9.
Dagna, Lorenzo, Andrea Iellem, Priscilla Biswas, et al.. (2002). Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 γ δ T lymphocytes. European Journal of Immunology. 32(10). 2934–2943. 16 indexed citations
10.
Gianotti, Luca, Marco Braga, Claudio Fortis, et al.. (1999). A Prospective, Randomized Clinical Trial on Perioperative Feeding With an Arginine‐, Omega‐3 Fatty Acid‐, and RNA‐Enriched Enteral Diet: Effect on Host Response and Nutritional Status. Journal of Parenteral and Enteral Nutrition. 23(6). 314–320. 131 indexed citations
11.
Fortis, Claudio, Priscilla Biswas, Laura Soldini, et al.. (1999). Dual role of TNF-α in NK / LAK cell-mediated lysis of chronically HIV-infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell-mediated lysis. European Journal of Immunology. 29(11). 3654–3662. 14 indexed citations
12.
Gianotti, Luca, Claudio Fortis, Marco Braga, et al.. (1997). Radical oncologic surgery affects the circulatory levels of interleukin 10. Journal of Surgical Oncology. 66(4). 244–247. 14 indexed citations
13.
Fortis, Claudio, Marco Foppoli, Luca Gianotti, et al.. (1996). Increased interleukin-10 serum levels in patients with solid tumours. Cancer Letters. 104(1). 1–5. 135 indexed citations
14.
Braga, Marco, Luca Gianotti, Oreste ­Gentilini, et al.. (1996). Thymopentin Modulates Th1 and Th2 Cytokine Response and Host Survival in Experimental Injury. Journal of Surgical Research. 62(2). 197–200. 9 indexed citations
15.
Citterio, Giovanni, Fabio Pellegatta, Gabriele Fragasso, et al.. (1996). Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2. British Journal of Cancer. 74(8). 1297–1301. 9 indexed citations
16.
Maffezzini, Massimo, Alchiede Simonato, & Claudio Fortis. (1996). Salvage immunotherapy with subcutaneous recombinant interleukin 2 (rIL-2) and alpha-interferon (A-IFN) for stage D3 prostate carcinoma failing second-line hormonal treatment. The Prostate. 28(5). 282–286. 19 indexed citations
17.
Fortis, Claudio, Laura Galli, Giuseppe Consogno, et al.. (1995). Serum Levels of Soluble Cell Adhesion Molecules (ICAM-1, VCAM-1, E-Selectin) and of Cytokine TNF-α Increase during Interleukin-2 Therapy. Clinical Immunology and Immunopathology. 76(2). 142–147. 10 indexed citations
18.
Besana, C, A Borri, Eugênio Bucci, et al.. (1994). Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous α-interferon. European Journal of Cancer. 30(9). 1292–1298. 16 indexed citations
19.
Clementi, Emilio, et al.. (1994). Reversible anergy in circulating lymphocytes of cancer patients during interleukin-2 therapy. Cancer Immunology Immunotherapy. 39(3). 167–171. 5 indexed citations
20.
Ferrarini, Marina, Elisabetta Ferrero, Claudio Fortis, Alessandro Poggi, & Maria Raffaella Zocchi. (1990). LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes. British Journal of Cancer. 62(5). 754–757. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026